The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Premarin-API Market Research Report 2024
Synopsis
Conjugated estrogens (CEs), or conjugated equine estrogens (CEEs), sold under the brand name Premarin among others, is an estrogen medication which is used in menopausal hormone therapy and for various other indications. It is a mixture of the sodium salts of estrogen conjugates found in horses, such as estrone sulfate and equilin sulfate. CEEs are available in the form of both natural preparations manufactured from the urine of pregnant mares and fully synthetic replications of the natural preparations. They are formulated both alone and in combination with progestins such as medroxyprogesterone acetate. CEEs are usually taken by mouth, but can also be given by application to the skin or vagina as a cream or by injection into a blood vessel or muscle.
The global Premarin-API market was valued at US$ 56 million in 2023 and is anticipated to reach US$ 73 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Premarin-API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Premarin-API.
Report Scope
The Premarin-API market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Premarin-API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Premarin-API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Xinjiang Tefeng
Segment by Type
0.97
97%UP
Segment by Application
Tablet
Cream
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Premarin-API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Premarin-API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Conjugated estrogens (CEs), or conjugated equine estrogens (CEEs), sold under the brand name Premarin among others, is an estrogen medication which is used in menopausal hormone therapy and for various other indications. It is a mixture of the sodium salts of estrogen conjugates found in horses, such as estrone sulfate and equilin sulfate. CEEs are available in the form of both natural preparations manufactured from the urine of pregnant mares and fully synthetic replications of the natural preparations. They are formulated both alone and in combination with progestins such as medroxyprogesterone acetate. CEEs are usually taken by mouth, but can also be given by application to the skin or vagina as a cream or by injection into a blood vessel or muscle.
The global Premarin-API market was valued at US$ 56 million in 2023 and is anticipated to reach US$ 73 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Premarin-API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Premarin-API.
Report Scope
The Premarin-API market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Premarin-API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Premarin-API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Xinjiang Tefeng
Segment by Type
0.97
97%UP
Segment by Application
Tablet
Cream
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Premarin-API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Premarin-API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Premarin-API Market Overview
1.1 Product Overview and Scope of Premarin-API
1.2 Premarin-API Segment by Type
1.2.1 Global Premarin-API Market Value Comparison by Type (2024-2030)
1.2.2 0.97
1.2.3 97%UP
1.3 Premarin-API Segment by Application
1.3.1 Global Premarin-API Market Value by Application: (2024-2030)
1.3.2 Tablet
1.3.3 Cream
1.4 Global Premarin-API Market Size Estimates and Forecasts
1.4.1 Global Premarin-API Revenue 2019-2030
1.4.2 Global Premarin-API Sales 2019-2030
1.4.3 Global Premarin-API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Premarin-API Market Competition by Manufacturers
2.1 Global Premarin-API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Premarin-API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Premarin-API Average Price by Manufacturers (2019-2024)
2.4 Global Premarin-API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Premarin-API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Premarin-API, Product Type & Application
2.7 Premarin-API Market Competitive Situation and Trends
2.7.1 Premarin-API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Premarin-API Players Market Share by Revenue
2.7.3 Global Premarin-API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Premarin-API Retrospective Market Scenario by Region
3.1 Global Premarin-API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Premarin-API Global Premarin-API Sales by Region: 2019-2030
3.2.1 Global Premarin-API Sales by Region: 2019-2024
3.2.2 Global Premarin-API Sales by Region: 2025-2030
3.3 Global Premarin-API Global Premarin-API Revenue by Region: 2019-2030
3.3.1 Global Premarin-API Revenue by Region: 2019-2024
3.3.2 Global Premarin-API Revenue by Region: 2025-2030
3.4 North America Premarin-API Market Facts & Figures by Country
3.4.1 North America Premarin-API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Premarin-API Sales by Country (2019-2030)
3.4.3 North America Premarin-API Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Premarin-API Market Facts & Figures by Country
3.5.1 Europe Premarin-API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Premarin-API Sales by Country (2019-2030)
3.5.3 Europe Premarin-API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Premarin-API Market Facts & Figures by Country
3.6.1 Asia Pacific Premarin-API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Premarin-API Sales by Country (2019-2030)
3.6.3 Asia Pacific Premarin-API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Premarin-API Market Facts & Figures by Country
3.7.1 Latin America Premarin-API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Premarin-API Sales by Country (2019-2030)
3.7.3 Latin America Premarin-API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Premarin-API Market Facts & Figures by Country
3.8.1 Middle East and Africa Premarin-API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Premarin-API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Premarin-API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Premarin-API Sales by Type (2019-2030)
4.1.1 Global Premarin-API Sales by Type (2019-2024)
4.1.2 Global Premarin-API Sales by Type (2025-2030)
4.1.3 Global Premarin-API Sales Market Share by Type (2019-2030)
4.2 Global Premarin-API Revenue by Type (2019-2030)
4.2.1 Global Premarin-API Revenue by Type (2019-2024)
4.2.2 Global Premarin-API Revenue by Type (2025-2030)
4.2.3 Global Premarin-API Revenue Market Share by Type (2019-2030)
4.3 Global Premarin-API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Premarin-API Sales by Application (2019-2030)
5.1.1 Global Premarin-API Sales by Application (2019-2024)
5.1.2 Global Premarin-API Sales by Application (2025-2030)
5.1.3 Global Premarin-API Sales Market Share by Application (2019-2030)
5.2 Global Premarin-API Revenue by Application (2019-2030)
5.2.1 Global Premarin-API Revenue by Application (2019-2024)
5.2.2 Global Premarin-API Revenue by Application (2025-2030)
5.2.3 Global Premarin-API Revenue Market Share by Application (2019-2030)
5.3 Global Premarin-API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Premarin-API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Premarin-API Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Xinjiang Tefeng
6.2.1 Xinjiang Tefeng Corporation Information
6.2.2 Xinjiang Tefeng Description and Business Overview
6.2.3 Xinjiang Tefeng Premarin-API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Xinjiang Tefeng Premarin-API Product Portfolio
6.2.5 Xinjiang Tefeng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Premarin-API Industry Chain Analysis
7.2 Premarin-API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Premarin-API Production Mode & Process
7.4 Premarin-API Sales and Marketing
7.4.1 Premarin-API Sales Channels
7.4.2 Premarin-API Distributors
7.5 Premarin-API Customers
8 Premarin-API Market Dynamics
8.1 Premarin-API Industry Trends
8.2 Premarin-API Market Drivers
8.3 Premarin-API Market Challenges
8.4 Premarin-API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
